Viswam S. Nair, MD MS

Pulmonologist

Instructor, Medicine - Pulmonary & Critical Care Medicine Instructor (By courtesy), Radiology - General Radiology

Chest Clinic

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-725-7061
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Board Certification: Critical Care Medicine, American Board of Internal Medicine (2010)

Bachelor of Arts, University of Pennsylvania, Chemistry (1998)

Medical Education: Ohio State University (6/2004) OH

Residency: Santa Clara Valley Medical Center (6/2007) CA

Fellowship: Stanford University Division of PCCM (6/2010) CA

Masters of Science, Stanford University, Clinical Epidemiology (2011)

Board Certification: Internal Medicine, American Board of Internal Medicine (2007)

Board Certification: Pulmonary Disease, American Board of Internal Medicine (2009)

Board Certification, Critical Care Medicine, American Board of Internal Medicine (2010)

Honors & Awards

Loan Repayment Program "In vivo and In vitro diagnostics to improve lung cancer care", NIH NCI (10/13-10/15)

In vivo and in vitro diagnostics for assessing the lung nodule, LUNGevity Foundation Career Development Award (07/12-07/15)

An analysis of early-stage NSCLC transcriptomics across varying FDG uptake levels on PET imaging, Lung Cancer Research Foundation (11/10-11/11)

PET-FDG uptake, gene expression and outcome in stage I resected lung adenocarcinoma, The CHEST Foundation, Clinical Research Award (07/09-07/10)

Administrative Appointments

Affiliate, Canary Center at Stanford for Cancer Early Detection (2013 - Present)

Instructor of medicine, Stanford University, Div of PCCM (2012 - Present)

Post-doctoral reseach fellow and clinical instructor, Stanford University, Division of Pulmonary & Critical Care (2010 - 2012)

Circulating Tumor Microemboli Diagnostics for Patients with Non-Small-Cell Lung Cancer
Carlsson, A., Nair, V. S., Luttgen, M. S., Keu, K. V., Horng, G., & Gambhir, S. S. (2014). Circulating Tumor Microemboli Diagnostics for Patients with Non-Small-Cell Lung Cancer. JOURNAL OF THORACIC ONCOLOGY, 9(8), 1111-1119.

Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies
Nair, V. S., Pritchard, C. C., Tewari, M., & Ioannidis, J. Pa. (2014). Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies. AMERICAN JOURNAL OF EPIDEMIOLOGY, 180(2), 140-152.

NF-kappa B protein expression associates with F-18-FDG PET tumor uptake in non-small cell lung cancer: A radiogenomics validation study to understand tumor metabolism
Nair, V. S., Gevaert, O., Davidzon, G., Plevritis, S. K., & West, R. (2014). NF-kappa B protein expression associates with F-18-FDG PET tumor uptake in non-small cell lung cancer: A radiogenomics validation study to understand tumor metabolism. LUNG CANCER, 83(2), 189-196.

A Dominant Adenocarcinoma With Multifocal Ground Glass Lesions Does Not Behave as Advanced Disease
Gu, B., Burt, B. M., Merritt, R. E., Stephanie, S., Nair, V., & Shrager, J. B. (2013). A Dominant Adenocarcinoma With Multifocal Ground Glass Lesions Does Not Behave as Advanced Disease. ANNALS OF THORACIC SURGERY, 96(2), 411-418.

An Observational Study of Circulating Tumor Cells and F-18-FDG PET Uptake in Patients with Treatment-Naive Non-Small Cell Lung Cancer
Nair, V. S., Keu, K. V., Luttgen, M. S., Kolatkar, A., Vasanawala, M., & Kuhn, P. (2013). An Observational Study of Circulating Tumor Cells and F-18-FDG PET Uptake in Patients with Treatment-Naive Non-Small Cell Lung Cancer. PLOS ONE, 8(7).

Circulating tumour cells in early breast cancer
Nair, V. S., Keu, K. V., Kuhn, P., & Gambhir, S. S. (2012). Circulating tumour cells in early breast cancer. LANCET ONCOLOGY, 13(9), E370-E371.

Prognostic PET F-18-FDG Uptake Imaging Features Are Associated with Major Oncogenomic Alterations in Patients with Resected Non-Small Cell Lung Cancer
Nair, V. S., Gevaert, O., Davidzon, G., Napel, S., Graves, E. E., & Plevritis, S. K. (2012). Prognostic PET F-18-FDG Uptake Imaging Features Are Associated with Major Oncogenomic Alterations in Patients with Resected Non-Small Cell Lung Cancer. CANCER RESEARCH, 72(15), 3725-3734.

Clinical Outcome Prediction by MicroRNAs in Human Cancer: A Systematic Review
Nair, V. S., Maeda, L. S., & Ioannidis, J. Pa. (2012). Clinical Outcome Prediction by MicroRNAs in Human Cancer: A Systematic Review. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 104(7), 528-540.

Fluorodeoxyglucose-PET Scanning in the Diagnosis of Pleural Disease
Nair, V. S. (2011). Fluorodeoxyglucose-PET Scanning in the Diagnosis of Pleural Disease. CHEST, 139(4), 966-967.

PET Scan F-18-Fluorodeoxyglucose Uptake and Prognosis in Patients With Resected Clinical Stage IA Non-small Cell Lung Cancer
Nair, V. S., Barnett, P. G., Ananth, L., & Gould, M. K. (2010). PET Scan F-18-Fluorodeoxyglucose Uptake and Prognosis in Patients With Resected Clinical Stage IA Non-small Cell Lung Cancer. CHEST, 137(5), 1150-1156.

Management of Lung Nodules Detected by Volume CT Scanning
Nair, V. S. (2010). Management of Lung Nodules Detected by Volume CT Scanning. NEW ENGLAND JOURNAL OF MEDICINE, 362(8), 757-757.

Positron Emission Tomography F-18-Fluorodeoxyglucose Uptake and Prognosis in Patients with Surgically Treated, Stage I Non-small Cell Lung Cancer: A Systematic Review
Nair, V. S., Krupitskaya, Y., & Gould, M. K. (2009). Positron Emission Tomography F-18-Fluorodeoxyglucose Uptake and Prognosis in Patients with Surgically Treated, Stage I Non-small Cell Lung Cancer: A Systematic Review. JOURNAL OF THORACIC ONCOLOGY, 4(12), 1473-1479.